FibroBiologics/$FBLG
1D1W1MYTD1Y5YMAX
About FibroBiologics
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
- Ticker
- $FBLG
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Houston, United States
- Website
- fibrobiologics.com
FibroBiologics Metrics
BasicAdvanced
$9.6M
-
-$4.77
1.17
-
Price and volume
Market cap
$9.6M
Beta
1.17
52-week high
$3.97
52-week low
$0.62
Average daily volume
205K
Financial strength
Current ratio
2.643
Quick ratio
1.588
Long term debt to equity
23.296
Total debt to equity
31.536
Interest coverage (TTM)
-77.81%
Profitability
EBITDA (TTM)
-16.466
Management effectiveness
Return on assets (TTM)
-95.77%
Return on equity (TTM)
-660.08%
Valuation
Price to book
1.89
Price to tangible book (TTM)
1.89
Price to free cash flow (TTM)
-0.37
Free cash flow yield (TTM)
-269.96%
Free cash flow per share (TTM)
-3.887
Growth
Earnings per share change (TTM)
-35.59%
3-year earnings per share growth (CAGR)
-13.06%
FibroBiologics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.